Schobel Alexander Mark 4
4 · Aquestive Therapeutics, Inc. · Filed Feb 9, 2021
Insider Transaction Report
Form 4
Schobel Alexander Mark
Chief Innovation/Tech Officer
Transactions
- Sale
Common Stock
2021-02-08$6.50/sh−40,792$265,148→ 872,000 total
Footnotes (1)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan previously adopted by the reporting person in this Form 4 on December 16, 2020.